Zobrazeno 1 - 10
of 82
pro vyhledávání: ''
Autor:
Xi Li, Simin Zhang, Linong Ji, Zhao-Qian Liu, Ji-Ye Yin, Hong-Hao Zhou, Wei Zhang, Xueyao Han, Rang-Ru Liu, Xiao-Ping Chen, Jun-Yan Liu, Di Xiao
Publikováno v:
Pharmacogenomics and Personalized Medicine
Di Xiao,1,2,* Jun-Yan Liu,3,* Si-Min Zhang,4,* Rang-Ru Liu,1,5 Ji-Ye Yin,1,6 Xue-Yao Han,4 Xi Li,1,6 Wei Zhang,1,6,7 Xiao-Ping Chen,1,6 Hong-Hao Zhou,1,6,7 Li-Nong Ji,4 Zhao-Qian Liu1,6,7 1Department of Clinical Pharmacology, Xiangya Hosp
Publikováno v:
Pharmacogenomics and Personalized Medicine
Shuai Ping,1 Siyuan Wang,1 Jinbing He,1 Jianghai Chen2 1Department of Orthopaedics, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430077, People’s Republic of China; 2Department of Hand Surgery, Unio
Autor:
Juan Wang, Junting Huang, Jia Zhu, Yizhuo Zhang, Xiaoqin Zhu, Yi Que, Zijun Zhen, Lian Zhang, Suying Lu, Feifei Sun, Ruiqing Cai, Dalei Zhou
Publikováno v:
Pharmacogenomics and Personalized Medicine
Xiaoqin Zhu,1,2,* Jia Zhu,1,2,* Feifei Sun,1,2,* Zijun Zhen,1,2 Dalei Zhou,1,3 Suying Lu,1,2 Junting Huang,1,2 Yi Que,1,2 Lian Zhang,1,2 Ruiqing Cai,1,2 Juan Wang,1,2 Yizhuo Zhang1,2 1State Key Laboratory of Oncology in South China, Collaborative Inn
Autor:
Dewi Selvina Rosdiana, Rianto Setiabudy, Djajadiman Gatot, Rizka Andalusia, Saptawati Bardosono, Melva Louisa, Instiaty Instiaty
Publikováno v:
Pharmacogenomics and Personalized Medicine
Dewi Selvina Rosdiana,1 Rianto Setiabudy,1 Rizka Andalusia,2,3 Djajadiman Gatot,4 Melva Louisa,1 Saptawati Bardosono,5 Instiaty Instiaty1 1Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; 2D
Autor:
Henriette E. Meyer zu Schwabedissen, Chiara Jeiziner, Markus L. Lampert, Céline K Stäuble, Kurt E. Hersberger
Publikováno v:
Pharmacogenomics and Personalized Medicine
Pharmacogenotyping is applied to determine the hereditable component of a patient's susceptibility to experience therapy failure and/or adverse drug reactions (ADRs). We present the case of a female patient diagnosed with breast cancer and treated wi
Publikováno v:
Pharmacogenomics and Personalized Medicine
Nermeen Abuelsoud,1,2 Hala Fayed,3 Engy Elkateeb4 1Department of Clinical Pharmacy Practice, Faculty of Pharmacy, The British University in Egypt, Cairo, Egypt; 2Department of Pharmacy Practice/Clinical Pharmacy, Faculty of Pharmacy, Egyptian Russian
Autor:
Katarzyna Bogunia-Kubik, Renata Sokolik, Lucyna Korman, Piotr Wiland, Jerzy Świerkot, Milena Iwaszko, Barbara Wysoczańska
Publikováno v:
Pharmacogenomics and Personalized Medicine
Renata Sokolik,1,* Milena Iwaszko,2,* Jerzy Åwierkot,1 Barbara WysoczaÅska,2 Lucyna Korman,1 Piotr Wiland,1 Katarzyna Bogunia-Kubik2 1Department of Rheumatology and Internal Medicine, WrocÅaw Medical University, WrocÅaw, Poland; 2Laborato
Publikováno v:
Pharmacogenomics and Personalized Medicine. 13:757-766
Introduction Platinum-based chemotherapy is the cornerstone of treatment for patients with LUSC, but cisplatin resistance greatly restricts its clinical application. Therefore, it is particularly important to screen the predominant LUSC population us
Publikováno v:
Expert Review of Vaccines. 19:1105-1114
There are currently no effective treatments for Methamphetamine (METH) addiction and psychotherapy remains the sole treatment option. The development of immunopharmacotherapies for the treatment of drug addiction, overdose, and relapse management app
Publikováno v:
Cancer Biol Ther
Small bowel cancer is a very rare disease. It can be treated by surgery at early stages; however, there is no standard therapeutic strategy established for the treatment of unresectable and/or metastatic diseases. Here we present a case of metastatic